Company / Current Assets
Glaukos Corp. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$475.0M
FY2025
5-year range
$395.5M / $486.1M
FY2021-FY2025
Trend
+5.6%
vs FY2024
Sector context
#116 of 165
Health Care
What the data says
At $475M, Glaukos Corp.'s current assets ranks #116 of 165 in the Health Care sector. Improved from $395M to $475M over the past 2 years.
Based on SEC 10-K filings.
$475M in FY2025 with a 5-year CAGR of +0.2%.
Improved from $395M to $475M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +2.3%
- 5-Year CAGR
- +0.2%
- 10-Year CAGR
- -
Sector benchmark
#116 of 165 in Health CareTop 70% of 165This company $475.0M Sector average $5.2B
▼
-90.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +0.2%, indicating consistent growth.
- In FY2025, current assets increased 5.6% year-over-year.
- Ranks #116 out of 165 companies in the Health Care sector.
- Peak current assets was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $475.0M | +5.6% |
| FY2024 | $449.8M | +13.7% |
| FY2023 | $395.5M | -10.9% |
| FY2022 | $443.9M | -8.7% |
| FY2021 | $486.1M | +3.6% |
| FY2020 | $469.4M | +78.6% |
| FY2019 | $262.9M | +48.9% |
| FY2018 | $176.6M | +18.1% |
| FY2017 | $149.5M | +24.5% |
| FY2016 | $120.0M | +15.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026